Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 2101 Records) |
Query Trace: PIK3CA[original query] |
---|
A Novel Germline Mutation of BRCA1 and Integrated Analysis With Somatic Mutation in a Chinese Multi-Cancer Family. The oncologist 2023 12 . Xiling Yang, Li Shang, Liren Yang, Landi Sun, Xiaoqian Tuo, Sijia Ma, Le Zhao, Xu Li, Wenfang Ya |
Multi-ancestry genome-wide association meta-analysis of Parkinson's disease. Nature genetics 2023 12 . Jonggeol Jeffrey Kim, Dan Vitale, Diego Véliz Otani, Michelle Mulan Lian, Karl Heilbron, , Hirotaka Iwaki, Julie Lake, Caroline Warly Solsberg, Hampton Leonard, Mary B Makarious, Eng-King Tan, Andrew B Singleton, Sara Bandres-Ciga, Alastair J Noyce, , Cornelis Blauwendraat, Mike A Nalls, Jia Nee Foo, Ignacio Ma |
Comparative genomic analysis of PIK3R1-mutated and wild-type breast cancers. Breast cancer research and treatment 2023 12 . Melody A Cobleigh, Kayla Viets Layng, Elizabeth Mauer, Brett Mahon, Adam J Hockenberry, Abde M Abukhde |
Prevalence and prognosis of PIK3CA mutations in Bulgarian patients with metastatic breast cancer receiving endocrine therapy in first-line setting. Cancer reports (Hoboken, N.J.) 2023 12 e1966. R Gencheva, M Petrova, P Kraleva, S Hadjidekova, M Radanova, N Conev, D Stoyanov, J Arabadjiev, E Tazimova, S Bachurska, M Eneva, M Tsvetkova, G Zhbantov, T Karanikolova, D Manov, A Ivanova, M Taushanova-Hadjieva, R Staneva, E Dimitrova, I Don |
DNA Copy Number Alterations and Copy Neutral Loss of Heterozygosity in Adult Ph-Negative Acute B-Lymphoblastic Leukemia: Focus on the Genes Involved. International journal of molecular sciences 2023 12 24 (24): . Natalya Risinskaya, Maria Gladysheva, Abdulpatakh Abdulpatakhov, Yulia Chabaeva, Valeriya Surimova, Olga Aleshina, Anna Yushkova, Olga Dubova, Nikolay Kapranov, Irina Galtseva, Sergey Kulikov, Tatiana Obukhova, Andrey Sudarikov, Elena Parovichniko |
Association of PIK3CA Mutation With Pathologic Complete Response and Outcome by Hormone Receptor Status and Intrinsic Subtype in Early-Stage ERBB2/HER2-Positive Breast Cancer. JAMA network open 2023 12 6 (12): e2348814. Paola Zagami, Aranzazu Fernandez-Martinez, Naim U Rashid, Katherine A Hoadley, Patricia A Spears, Giuseppe Curigliano, Charles M Perou, Lisa A Car |
Association of ESR1 germline variants with TP53 somatic variants in breast tumors in a genome-wide study. medRxiv : the preprint server for health sciences 2023 12 . Nijole P Tjader, Abigail J Beer, Johnny Ramroop, Mei-Chee Tai, Jie Ping, Tanish Gandhi, Cara Dauch, Susan L Neuhausen, Elad Ziv, Nereida Sotelo, Shreya Ghanekar, Owen Meadows, Monica Paredes, Jessica Gillespie, Amber Aeilts, Heather Hampel, Wei Zheng, Guochong Jia, Qiang Hu, Lei Wei, Song Liu, Christine B Ambrosone, Julie R Palmer, John D Carpten, Song Yao, Patrick Stevens, Weang-Kee Ho, Jia Wern Pan, Paolo Fadda, Dezheng Huo, Soo-Hwang Teo, Joseph Paul McElroy, Amanda Ewart Tola |
Clinicopathologic and genetic analysis of invasive breast carcinomas in women with germline CHEK2 variants. Breast cancer research and treatment 2023 12 . Christopher J Schwartz, Nikka Khorsandi, Amie Blanco, Rita A Mukhtar, Yunn-Yi Chen, Gregor Krin |
Construction of a risk stratification model integrating ctDNA to predict response and survival in neoadjuvant-treated breast cancer. BMC medicine 2023 12 21 (1): 493. Zhaoyun Liu, Bo Yu, Mu Su, Chenxi Yuan, Cuicui Liu, Xinzhao Wang, Xiang Song, Chao Li, Fukai Wang, Jianli Ma, Meng Wu, Dawei Chen, Jinming Yu, Zhiyong |
Higher TP53 somatic mutation prevalence from liquid biopsy analysis in ever smoker non-small-cell lung cancer patients. Mutation research 2023 12 828 111847. Haktan Ba??? Erdem, Mustafa Tar?k Alay, Zeynep Özdemir, Ezgi Çevik, Öztürk Ate?, Cengiz Karaçin, ?brahim ?ahin, Mutlu Do?an, Taha Bah |
Genomic Landscape of Circulating Tumor DNA in Patients With Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor-2-Negative Metastatic Breast Cancer Treated With Abemaciclib: Data From the SCRUM-Japan Cancer Genome Screening Project. JCO precision oncology 2024 4 8 e2300647. Masaya Hattori, Victoria Serelli-Lee, Yoichi Naito, Takashi Yamanaka, Hiroyuki Yasojima, Rikiya Nakamura, Takao Fujisawa, Mitsuho Imai, Yoshiaki Nakamura, Hideaki Bando, Tsutomu Kawaguchi, Takayuki Yoshino, Hiroji Iwa |
Prevalence and Associations of Co-occurrence of NFE2L2 Mutations and Chromosome 3q26 Amplification in Lung Cancer. Global medical genetics 2024 4 11 (2): 150-158. Jinfeng Liu, Sijie Liu, Dan Li, Hongbin Li, Fan Zha |
Integrated mutational landscape analysis of poorly differentiated high-grade neuroendocrine carcinoma of the uterine cervix. Proceedings of the National Academy of Sciences of the United States of America 2024 4 121 (17): e2321898121. Stefania Bellone, Kyungjo Jeong, Mari Kyllesø Halle, Camilla Krakstad, Blair McNamara, Michelle Greenman, Levent Mutlu, Cem Demirkiran, Tobias Max Philipp Hartwich, Yang Yang-Hartwich, Margherita Zipponi, Natalia Buza, Pei Hui, Francesco Raspagliesi, Salvatore Lopez, Biagio Paolini, Massimo Milione, Emanuele Perrone, Giovanni Scambia, Gary Altwerger, Antonella Ravaggi, Eliana Bignotti, Gloria S Huang, Vaagn Andikyan, Mitchell Clark, Elena Ratner, Masoud Azodi, Peter E Schwartz, Charles M Quick, Roberto Angioli, Corrado Terranova, Samir Zaidi, Shuvro Nandi, Ludmil B Alexandrov, Eric R Siegel, Jungmin Choi, Joseph Schlessinger, Alessandro D Sant |
Correlation between NGS panel-based mutation results and clinical information in colorectal cancer patients. Heliyon 2024 4 10 (7): e29299. Bo Cheng, Lin Xu, Yunzhi Zhang, Huimin Yang, Shan Liu, Shanshan Ding, Huan Zhao, Yi Sui, Chan Wang, Lanju Quan, Jinhong Liu, Ye Liu, Hongming Wang, Zhaoqing Zheng, Xizhao Wu, Jing Guo, Zhaohong Wen, Ruya Zhang, Fei Wang, Hongmei Liu, Suozhu S |
Understanding PI3K/Akt/mTOR signaling in squamous cell carcinoma: mutated PIK3CA as an example. Molecular biomedicine 2024 4 5 (1): 13. Shutao Zheng, Shuo He, Yan Liang, Yiyi Tan, Qing Liu, Tao Liu, Xiaomei |
The Molecular Landscape of Gastric Cancers for Novel Targeted Therapies from Real-World Genomic Profiling. Targeted oncology 2024 4 . Hiroyuki Yamamoto, Hiroyuki Arai, Ritsuko Oikawa, Kumiko Umemoto, Hiroyuki Takeda, Takuro Mizukami, Yohei Kubota, Ayako Doi, Yoshiki Horie, Takashi Ogura, Naoki Izawa, Jay A Moore, Ethan S Sokol, Yu Sunaka |
Association of preoperative and postoperative circulating tumour DNA (ctDNA) with PIK3CA gene mutation with risk of recurrence in patients with non-metastatic breast cancer. Surgical oncology 2024 4 54 102060. Fara Hassan, Jiang Huai Wang, Donal Peter O'Leary, Mark Corrigan, Henry Paul Redmo |
Non-invasive decision support for clinical treatment of non-small cell lung cancer using a multiscale radiomics approach. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2024 1 191 110082. Xingping Zhang, Guijuan Zhang, Xingting Qiu, Jiao Yin, Wenjun Tan, Xiaoxia Yin, Hong Yang, Hua Wang, Yanchun Zha |
Clinical-Molecular characteristics and Post-Translational modifications of colorectal cancer in north China: Implications for future targeted therapies. Gene 2024 1 899 148134. Yajing Chi, Hongtu Yuan, Qing Fan, Zhendan Wang, Zuoxing Niu, Jinming Yu, Dandan Yu |
p4EBP1 staining predicts outcome in ER-positive endocrine-resistant metastatic breast cancer patients treated with everolimus and exemestane. British journal of cancer 2024 1 . Hélène Vanacker, Isabelle Treilleux, Camille Schiffler, Ivan Bieche, Mario Campone, Anne Patsouris, Monica Arnedos, Paul H Cottu, Jean-Philippe Jacquin, Florence Dalenc, Antoine Pinton, Nicolas Servant, Valéry Attignon, Etienne Rouleau, Alain Morel, François Legrand, Marta Jimenez, Fabrice Andre, Thomas Bachel |
TIROSEC: Molecular, Clinical and Histopathological Profile of Papillary Thyroid Carcinoma in a Colombian Cohort. Advances in therapy 2024 1 . Sergio D Cruz-Romero, Sebastián González, José Y Juez, David S Becerra, Ana M Baldión, José A Hakim, Deyanira González-Devia, Sandra Perdomo, Paula A Rodríguez-Urre |
Genomic Alterations of Tumors in HER2-Low Breast Cancers. International journal of molecular sciences 2024 1 25 (2): . Yi-Fang Tsai, Chi-Cheng Huang, Chih-Yi Hsu, Chin-Jung Feng, Yen-Shu Lin, Ta-Chung Chao, Jiun-I Lai, Pei-Ju Lien, Chun-Yu Liu, Jen-Hwey Chiu, Ling-Ming Tse |
Chromosome 3p gene alterations as biomarkers for immunocombinations in metastatic renal cell carcinoma: A hypothesis-generating analysis. Pathology, research and practice 2024 1 254 155142. Matteo Rosellini, Veronica Mollica, Andrea Marchetti, Sara Coluccelli, Francesca Giunchi, Elisa Tassinari, Costantino Ricci, Michelangelo Fiorentino, Giovanni Tallini, Dario De Biase, Francesco Massa |
Genetic characterization and mutational profiling of foramen magnum meningiomas: a multi-institutional study. Journal of neurosurgery 2024 1 1-7. Lingyang Hua, Majd Alkhatib, Shingo Fujio, Boshr Alhasan, Sylvia Herold, Silke Zeugner, Amir Zolal, Mido M Hijazi, Victoria E Clark, Hiroaki Wakimoto, Ganesh M Shankar, Priscilla K Brastianos, Frederick G Barker, Daniel P Cahill, Leihao Ren, Ilker Y Eyüpoglu, Ye Gong, Gabriele Schackert, Tareq A Jurat |
Efficacy and Safety of Phosphatidylinositol 3-kinase Inhibitors for Patients with Breast Cancer: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Current cancer drug targets 2024 1 . Yi Wang, Xianling Du, Hongqiang Xin, Ruimin |
Integrated genomic and transcriptomic analysis reveals the activation of PI3K signaling pathway in HPV-independent cervical cancers. British journal of cancer 2024 1 . Yi Wang, Misi He, Tiancong He, Xueyan Ouyang, Xuxia Shen, Wanling Shi, Shengling Huang, Libing Xiang, Dongling Zou, Wei Jiang, Huijuan Ya |
Evaluation of potential biomarkers for lenvatinib plus pembrolizumab among patients with advanced endometrial cancer: results from Study 111/KEYNOTE-146. Journal for immunotherapy of cancer 2024 1 12 (1): . Vicky Makker, Matthew H Taylor, Carol Aghajanian, Allen L Cohn, Marcia S Brose, Christopher Di Simone, Zhu Alexander Cao, Leah Suttner, Andrey Loboda, Razvan Cristescu, Petar Jelinic, Robert Orlowski, Lea Dutta, Junji Matsui, Corina E Dutcus, Yukinori Minoshima, Mark J Messi |
Comprehensive genomic evaluation of advanced and recurrent breast cancer patients for tailored precision treatments. BMC cancer 2024 1 24 (1): 85. Mirai Ido, Kimihito Fujii, Hideyuki Mishima, Akihito Kubo, Masayuki Saito, Hirona Banno, Yukie Ito, Manami Goto, Takahito Ando, Yukako Mouri, Junko Kousaka, Tsuneo Imai, Shogo Naka |
A Phase II Exploratory Study to Identify Biomarkers Predictive of Clinical Response to Regorafenib in Patients with Metastatic Colorectal Cancer Who Have Failed First-Line Therapy. International journal of molecular sciences 2024 1 25 (1): . Karen Gambaro, Maud Marques, Suzan McNamara, Mathilde Couetoux du Tertre, Cyrla Hoffert, Archana Srivastava, Anna Schab, Thierry Alcindor, Adrian Langleben, Lucas Sideris, Mahmoud Abdelsalam, Mustapha Tehfe, Felix Couture, Gerald Batist, Petr Kav |
Genomic Landscape of Endometrial, Ovarian, and Cervical Cancers in Japan from the Database in the Center for Cancer Genomics and Advanced Therapeutics. Cancers 2024 1 16 (1): . Qian Xi, Hidenori Kage, Miho Ogawa, Asami Matsunaga, Akira Nishijima, Kenbun Sone, Kei Kawana, Katsutoshi O |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: